Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
new york blog main
5
×
san francisco blog main
boston blog main
national top stories
new york top stories
san diego blog main
san diego top stories
san francisco top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
deals
democrats
fda
investing
ipo
medical device
republicans
startups
vc
10x genomics
adaptive biotechnologies
What
public
5
×
ipo
week
companies
drugs
haul
life
science
advance
america
answer
away
bio
biogen
biology
biotech
biotechs
boost
club
company
continued
continues
convoluted
crop
cytokine
democratic
democrats
dems
discontent
dreams
election
enhanced
exceeded
files
firms
followed
genomics
group
head
headaches
Language
unset
Current search:
public
×
" new york blog main "
×
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M